company background image
688526 logo

Wuhan Keqian BiologyLtd SHSE:688526 Stock Report

Last Price

CN¥13.19

Market Cap

CN¥6.1b

7D

1.2%

1Y

-43.3%

Updated

23 Jul, 2024

Data

Company Financials +

Wuhan Keqian Biology Co.,Ltd

SHSE:688526 Stock Report

Market Cap: CN¥6.1b

688526 Stock Overview

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

688526 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Wuhan Keqian Biology Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Wuhan Keqian BiologyLtd
Historical stock prices
Current Share PriceCN¥13.19
52 Week HighCN¥24.12
52 Week LowCN¥12.80
Beta0.58
11 Month Change-14.90%
3 Month Change-25.73%
1 Year Change-43.34%
33 Year Change-54.53%
5 Year Changen/a
Change since IPO-58.23%

Recent News & Updates

Recent updates

We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Jun 26
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Apr 08
Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Apr 05
Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Mar 20
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Shareholder Returns

688526CN PharmaceuticalsCN Market
7D1.2%3.0%0.5%
1Y-43.3%-13.4%-16.6%

Return vs Industry: 688526 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.

Return vs Market: 688526 underperformed the CN Market which returned -16.6% over the past year.

Price Volatility

Is 688526's price volatile compared to industry and market?
688526 volatility
688526 Average Weekly Movement4.7%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 688526's share price has been volatile over the past 3 months.

Volatility Over Time: 688526's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001923Mulin Chenwww.kqbio.com

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was incorporated in 2001 and is based in Wuhan, China.

Wuhan Keqian Biology Co.,Ltd Fundamentals Summary

How do Wuhan Keqian BiologyLtd's earnings and revenue compare to its market cap?
688526 fundamental statistics
Market capCN¥6.13b
Earnings (TTM)CN¥347.63m
Revenue (TTM)CN¥989.49m

17.6x

P/E Ratio

6.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688526 income statement (TTM)
RevenueCN¥989.49m
Cost of RevenueCN¥326.45m
Gross ProfitCN¥663.04m
Other ExpensesCN¥315.41m
EarningsCN¥347.63m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)0.75
Gross Margin67.01%
Net Profit Margin35.13%
Debt/Equity Ratio4.8%

How did 688526 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

58%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.